Fasting insulin and uric acid levels but not indices of iron metabolism are independent predictors of non-alcoholic fatty liver disease. A case-control study-Reference-Cited by-同舟云学术

Fasting insulin and uric acid levels but not indices of iron metabolism are independent predictors of non-alcoholic fatty liver disease. A case-control study

Published:2002-03 Issue:3 Volume:34 Page:204-211
ISSN:1590-8658
Container-title:Digestive and Liver Disease
language:en
Short-container-title:Digestive and Liver Disease

Author:

Lonardo A.,Loria P.,Leonardi F.,Borsatti A.,Neri P.,Pulvirenti M.,Verrone A.M.,Bagni A.,Bertolotti M.,Ganazzi D.,Carulli N.

Publisher

Elsevier BV

Subject

Gastroenterology,Hepatology

Reference68 articles.

1. Nonalcoholic steatohepatitis;Sheth;Ann Intern Med,1997

2. Nonalcoholic fatty liver disease: a spectrum of clinical and pathologic severity;Matteoni;Gastroenterology,1999

3. Prevalence of and risk factors for hepatic steatosis in Northern Italy;Bellentani;Ann Intern Med,2000

4. The clinical significance of slightly to moderately increased liver transaminase values in asymptomatic patients;Mathiesen;Scand J Gastroenterol,1999

5. Prospective evaluation of unexplained chronic liver transaminase abnormalities in asymptomatic and symptomatic patients;Daniel;Am J Gastroenterol,1999

Cited by 108 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. From Hypothalamic Obesity to Metabolic Dysfunction-Associated Steatotic Liver Disease: Physiology Meets the Clinics via Metabolomics;Metabolites;2024-07-26

2. Associations of serum uric acid levels and anthropometric parameters with non-alcoholic fatty liver disease in healthy individuals: innovative insights from a cross-sectional study;Current Medical Research and Opinion;2023-12-23

3. What Is in a Name: from NAFLD to MAFLD and MASLD—Unraveling the Complexities and Implications;Current Hepatology Reports;2023-10-26

4. Expanding Pharmacists’ Role in the Management of Non-Alcoholic Fatty Liver Disease;Pharmacy;2023-09-21

5. Iron depletion in “metabolic fatty liver syndromes”: a strong biological rationale with disappointing liver outcomes;Exploration of Drug Science;2023-08-28